Trump drug pricing plan

Drugmakers sue to block rule requiring drug prices in TV ads

A street sign in front of a building near Amgen headquarters
Amgen is one of 3 drugmakers suing the Trump administration. Photo: Al Seib/Los Angeles Times via Getty Images

Amgen, Eli Lilly, Merck and the Association of National Advertisers are suing the Trump administration over its rule forcing pharmaceutical companies to display drugs' list prices in TV commercials. They say the rule violates the First Amendment and exceeds the government's authority.

The big picture: Experts expected drugmakers to file such a lawsuit — even though the new regulation isn't expected to actually affect drug pricing.

The Trump administration's coming health care regulations

White House officials are finalizing a handful of health care regulations, which means the rules will be released in short order.

The bottom line: These rules represent some of the biggest changes to the health care industry under the Trump administration.